248 related articles for article (PubMed ID: 26681039)
1. Association of the interleukin-6 gene -572G/C polymorphism with cancer risk: a meta-analysis.
Zhao Q; Zhang B; Chen Y; Li M; Zhao X; Fan H; Li SM
Genet Mol Res; 2015 Dec; 14(4):16921-8. PubMed ID: 26681039
[TBL] [Abstract][Full Text] [Related]
2. Lack of an association between interleukin-6 gene promoter polymorphisms (-174G/C, -572G/C) and ischemic heart disease and/or ischemic stroke: a meta-analysis.
Ma Y; Tang RK; Yang X; Peng GG; Liu Y; Wang XM; Wu BH; Yu JM
Hum Immunol; 2011 Aug; 72(8):641-51. PubMed ID: 21536090
[TBL] [Abstract][Full Text] [Related]
3. Association between Interleukin-6 gene -572G>C polymorphism and coronary heart disease.
Song C; Liu B; Yang D; Diao H; Zhao L; Lu Y; Yu Y; Guo Z; Zhang J; Liu J; Zaho Z; Zhang X
Cell Biochem Biophys; 2015 Jan; 71(1):359-65. PubMed ID: 25312476
[TBL] [Abstract][Full Text] [Related]
4. The association between interleukin-6 gene polymorphisms and intracranial aneurysms: a meta-analysis.
Zheng S; Su A; Sun H; You C
Hum Immunol; 2013 Dec; 74(12):1679-83. PubMed ID: 23993981
[TBL] [Abstract][Full Text] [Related]
5. Association between the -607 C > A polymorphism in interleukin-18 gene promoter with gastrointestinal cancer risk: a meta-analysis.
Yao J; Li ZH; Li YX; Zhang R; Zhang DG; Xu ZL; Wang LS; Wang JY
Genet Mol Res; 2015 Dec; 14(4):16880-7. PubMed ID: 26681034
[TBL] [Abstract][Full Text] [Related]
6. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL
Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871
[TBL] [Abstract][Full Text] [Related]
7. Lack of association between IL-6 -174G>C polymorphism and lung cancer: a meta-analysis.
Liu Y; Song XL; Zhang GL; Peng AM; Fu PF; Li P; Tan M; Li X; Li M; Wang CH
Genet Mol Res; 2015 Jan; 14(1):163-9. PubMed ID: 25729947
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 gene -572G/C polymorphism and prostate cancer risk.
Wang Y; Chen X; Chen Y
Afr Health Sci; 2018 Jun; 18(2):267-272. PubMed ID: 30602952
[TBL] [Abstract][Full Text] [Related]
9. Relationship between polymorphisms in -572G/C interleukin 6 promoter gene polymorphisms (rs1800796) and risk of rheumatoid arthritis: A meta-analysis.
Zhang C; Jiao S; Li T; Zhao L; Chen H
Int J Rheum Dis; 2020 Jan; 23(1):47-54. PubMed ID: 31782615
[TBL] [Abstract][Full Text] [Related]
10. Association of interleukin-6 gene polymorphisms with the risk of hepatocellular carcinoma: An up-to-date meta-analysis.
An PP; Feng LN; Zhang XX; Jin QL
Medicine (Baltimore); 2020 Dec; 99(50):e23659. PubMed ID: 33327352
[TBL] [Abstract][Full Text] [Related]
11. Association between the interleukin-6-174 G/C polymorphism and risk of ischemic stroke: a meta-analysis.
Jin XF; Wang DL; Zhou Y; Xiong H
Genet Mol Res; 2015 Oct; 14(4):13076-83. PubMed ID: 26535620
[TBL] [Abstract][Full Text] [Related]
12. No association between IL-1β -31 C/T polymorphism and the risk of duodenal ulcer: a meta-analysis of 3793 subjects.
Zhang BB; Wang J; Bian DL; Chen XY
Hum Immunol; 2012 Nov; 73(11):1200-6. PubMed ID: 22917539
[TBL] [Abstract][Full Text] [Related]
13. No association between IL-1β -511 C/T polymorphism and the risk of duodenal ulcer: a meta-analysis of 4667 subjects.
Zhang BB; Yin YW; Sun QQ
Gene; 2012 Sep; 506(1):188-94. PubMed ID: 22759516
[TBL] [Abstract][Full Text] [Related]
14. Association of the IL6 polymorphism rs1800796 with cancer risk: a meta-analysis.
Du Y; Gao L; Zhang K; Wang J
Genet Mol Res; 2015 Oct; 14(4):13236-46. PubMed ID: 26535637
[TBL] [Abstract][Full Text] [Related]
15. MTHFR A1298C polymorphism and ovarian cancer risk: a meta-analysis.
Shi XY; Shen Q
Genet Mol Res; 2015 Jul; 14(3):8211-8. PubMed ID: 26345746
[TBL] [Abstract][Full Text] [Related]
16. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
[TBL] [Abstract][Full Text] [Related]
17. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
[TBL] [Abstract][Full Text] [Related]
18. Lack of association between the cyclooxygenase 2 -765G>C polymorphism and prostate cancer risk: a meta-analysis.
Feng YQ; Li YU; Xiao WD; Wang GX; Li YO
Genet Mol Res; 2015 Oct; 14(4):13391-402. PubMed ID: 26535654
[TBL] [Abstract][Full Text] [Related]
19. Implicating the H63D polymorphism in the HFE gene in increased incidence of solid cancers: a meta-analysis.
Shen LL; Gu DY; Zhao TT; Tang CJ; Xu Y; Chen JF
Genet Mol Res; 2015 Oct; 14(4):13735-45. PubMed ID: 26535689
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6-174G > C (rs1800795) polymorphism distribution and its association with rheumatoid arthritis: A case-control study and meta-analysis.
Dar SA; Haque S; Mandal RK; Singh T; Wahid M; Jawed A; Panda AK; Akhter N; Lohani M; Areeshi MY; Rai G; Datt S; Bhattacharya SN; Ramachandran VG; Das S
Autoimmunity; 2017 May; 50(3):158-169. PubMed ID: 28010120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
